Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Why are vaccine units not functional, asks SC
The Supreme Court asked the central government as to why it was not making functional or upgrading its own vaccines manufacturing units, and instead procuring the vaccines from the market.
- Read more about Pfizer, Abbott and Macleods received temporary relief from Governments ban
Delhi high court gave temporary relief to Pfizer, Abbott and Macelods over health ministry's ban on certain fixed dose combinations (FDCs). The permit is provided till 21st march from governments ban on these companies products.
- Read more about Cheap, portable biosensor to keep tab on Alzheimer's progress
A team of researchers led by an Indian-American scientist has developed a portable biosensor that can display the progress of Alzheimer's disease in a patient.

[adsense:336x280:8701650588]
- Read more about Novel nanoparticle can spot and treat deadly heart disease
Offering a potential new approach to preventing deadly heart attacks and strokes, Indian-origin researchers have designed a synthetic nanoparticle that can simultaneously light up invisible plaque build up inside the arteries and also treat it.
- Read more about FDA accepts Amgen's Biologics license application
Amgen announced that the U.S. Food and Drug Administration (FDA) has accepted for review Amgen's supplemental Biologics License Application (sBLA) for the expanded use of Enbrel® (etanercept) to treat pediatric patients with chronic severe plaque psoriasis.
- Read more about Merck applauds the U.S. department of veterans affairs
Merck, known as MSD outside the United States and Canada, applauds the U.S. Department of Veterans Affairs (VA) for broadening access to treatment for Veterans with chronic hepatitis C virus (HCV) infection.
15 March 2016

Opening for Senior Scientific Officer at University of East London

UEL’s ambition is to become London’s leading university for civic engagement. We are a vibrant and diverse university located in the heart of east London. Our new corporate plan sets an ambitious agenda for our future success and growth which focuses on the delivery of high quality teaching and learning, and excellence in research.
- Read more about Teva Pharmaceuticals launched generic of Budesonide
Teva Pharmaceutical Industries Ltd. announced the launch of the generic equivalent to Pulmicort Respules® (budesonide inhalation suspension), 1 mg/2 mL, in the United States.
- Read more about Dr Reddy’s lab joined with TR-Pharm for manufacture and commercialization of bisimilars in Turky
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and TR-Pharm announced today a strategic collaboration agreement involving 3 biosimilar products. A total of three products will be registered and subsequently commercialized as a part of this agreement by TR-Pharm in Turkey. TR-Pharm will also manufacture the drug substance and drug product upon completition of its facility investment.
- Read more about Pfizer’s crizotinib got FDA nod
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for XALKORI® (crizotinib) to treat patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ROS1-positive. In 2015, the FDA granted Breakthrough Therapy and Priority Review designations for this indication. XALKORI also is indicated for patients with metastatic NSCLC whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.